Synthomer (GB:SYNT) has released an update.
Synthomer PLC reported modest financial growth in their interim results for H1 2024, with a slight revenue increase of 3.5% in constant currency terms and a 7.6% rise in EBITDA, indicating operational progress and self-help actions. Despite challenging market conditions and limited evidence of a broad-based recovery, the company is on track for positive Free Cash Flow for the year and is strategically focusing on higher margin speciality solutions to enhance future resilience and profitability.
For further insights into GB:SYNT stock, check out TipRanks’ Stock Analysis page.
